Cohorting patients has long been one of the most consequential and least visible steps in healthcare analytics. Whether the goal is real-world evidence (RWE), health economics and outcomes research (HEOR), clinical development, or commercial planning, nearly every downstream insight depends on a deceptively simple act: defining who counts.
Cohort construction is rarely discussed outside of technical teams. It is often treated as a mechanical query-building exercise rather than what it truly is: a transaction of clinical meaning into computable logic executed against fragmented, imperfect data.
As artificial intelligence becomes embedded across healthcare analytics, cohorting is undergoing a quiet but important shift. The transformation is not just about conversational interfaces or faster query generation. It is about rebuilding the architecture underneath cohort construction itself. What is now emerging is a more structural shift: AI-powered workflows that recognize cohorting as a multidimensional problem spanning clinical nuance, coding variability, and temporal logic and therefore treated as a sequence of explicit, validated steps rather than a single opaque operation.
Cohorting is not one problem; it is a chain of interdependent ones with each step dependent on the integrity of the one before it. A valid cohort definition must correctly interpret clinical concepts, apply inclusion and exclusion criteria, reason over time, and execute against messy real-world data. If patient identity is unstable, longitudinal logic breaks. If clinical concepts are poorly mapped, inclusion criteria drift. If execution is opaque, validation becomes guesswork.
Real-world data compounds the challenge. Claims and EHR data are incomplete by design. Patient journeys are fragmented across payers and systems, and coding conventions vary. Small inconsistencies, like an inclusion window applied incorrectly or a misinterpreted medication class, can materially alter patient counts or bias downstream analyses.
Healthcare data presents another challenge: it is encoded, not semantic. Diagnoses, procedures, medications, labs, and encounters are represented through vocabularies such as ICD-10, CPT, HCPCS, NDC, and LOINC. These systems were designed for billing and documentation, not for analytical clarity.
What appears to be a straightforward clinical concept, such as patients with Type 2 Diabetes on metformin and at least two BMI measurements above 35 in the past two years, rapidly expands into hundreds of discrete codes across diagnosis, procedure, laboratory, and pharmacy vocabularies. Semantic mapping is the process of translating that clinical intent into defensible, executable logic across these vocabularies.
Traditional approaches manage this complexity through manual rigor: carefully written SQL, manual code lookup, iterative validation, and expert review. While effective, this model does not scale. It limits how many questions an organization can reasonably ask and how quickly it can adapt to new evidence.
Why single layers fall short
Many AI-enabled analytics tools attempt to simplify cohorting by using a single large language model to translate natural language into executable logic. While this can accelerate basic queries, it struggles when precision, explainability, and reproducibility are required.
A single model is asked to interpret intent, apply clinical logic, manage temporal relationships, execute queries, validate results, and explain outcomes simultaneously. When errors occur, it is difficult to pinpoint their source or assess their impact. In environments where reproducibility and auditability matter, opacity constrains trust.
A workflow alternative
A more durable approach is to treat cohorting as a workflow rather than a single AI task. In this model, the process is decomposed into discreet stages with each handled by a specialized component designed for that purpose.
These workflow-oriented designs use an agent-based architecture in which different models handle intent interpretation, clinical concept resolution, temporal reasoning, execution, validation and explanation. Each step produces immediate outputs that can be inspected, reviewed, and refined.
This mirrors how experienced analysts already work but now with automation applied at each stage. The result is faster iteration without sacrificing clarity about how a cohort was constructed or why it may have changed.
One of the most visible effects of workflow-based cohorting is speed. Definitions that previously required weeks of back-and-forth can now be explored in hours. Plain-language inputs can be refined iteratively, with patient counts returned at each step.
For teams working in HEOR, RWE, or clinical development, this changes the economics of exploration. Instead of prioritizing a small number of “safe” analyses, teams can test more hypotheses, examine edge cases, and explore rare subpopulations that would otherwise be impractical.
Crucially, this acceleration does not come from lowering standards. Workflow-based systems rely on domain-specific, validated models rather than general-purpose language models. Outputs are transparent, with executable logic and audit trails available for review. Validation against ground truth datasets is built into the workflow. This emphasis on reproducibility and explainability is what allows AI-assisted cohorting to move beyond experimentation into routine use.
Where the intelligence runs matters
Another important shift concerns deployment. Many AI tools require data to be moved into separate environments to access advanced functionality, introducing friction around security, governance, and operational trust.
An alternative pattern is to deploy analytical services within existing data environments. In this approach, data remains in place while analytical logic is brought to it. This model aligns more naturally with healthcare organizations’ privacy and governance requirements and lowers barriers to adoption. It also enables natural-language cohorting to function as an embedded capability rather than a standalone application. Teams can invoke workflows through APIs, analytics notebooks, and multi-agent systems, integrating them into tools they already use.
Organizations using AI-powered cohort workflows report substantial gains in efficiency. Definitions that once required weeks of programming and validation can now be explored in minutes with logic and assumptions surfaced explicitly. More broadly, this points to a shift in how cohorting is viewed. Rather than a bespoke one-off exercise, cohort definitions become reusable assets. Logic can be standardized, refined, and shared across teams. Over time, cohorting evolves into part of an organization’s analytical infrastructure rather than a recurring technical hurdle.
The larger implication
The significance of AI-powered cohorting lies less in the interface and more in the workflow designed underneath it. By breaking complex analytical tasks into explicit, validated steps, organizations can move faster while maintaining rigor.
In healthcare analytics, where downstream decisions depend so heavily on who is counted and why, this shift may prove more consequential than many higher-profile applications of AI. It is not about replacing expertise but about encoding it into systems that scale. The organizations that benefit the most from AI-powered cohorting will not simply be those that move faster. They will be those that embed patient mastering and semantic rigor into reproduceable, inspectable workflows.
As evidence increasingly drives both clinical and commercial decisions, the ability to generate cohorts that are fast, transparent, and defensible may become one of the most important capabilities healthcare organizations build. But cohort generation is only the starting point. Value comes from interrogating the population, validating definitions, exploring outcomes and treatment patterns, and conducting downstream statistical analyses. Insights are refined through iteration by adjusting criteria, testing assumptions, and pressure-testing results until the findings are robust enough to inform trail design, regulatory strategy, market access decisions, and clinical practice.
Photo: ismagilov, Getty Images
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.